Table 3 The effect of RAPS on generic ADL (Models A1–3 N = 128; Models B1–3 N = 130)

OR (95% CI)

OR (95% CI)

OR (95% CI)

OR (95% CI)

OR (95% CI)

OR (95% CI)

RAPS, T1

1.02 (0.96–1.09)

1.02 (0.96–1.09)

1.32 (0.96–1.81)

1.02 (0.96–1.09)

1.03 (0.97–1.09)

1.76 (1.09–2.81)*

Functional limitations, T1

2.4 (1.75–3.28)***

2.29 (1.66–3.15)***

2.31 (1.68–3.2)***

2.41 (1.76–3.3)***

2.5 (1.77–3.53)***

2.9 (1.9–4.41)***

External HCB, T1

1.04 (0.99–1.09)

1.05 (0.99–1.11)

RAPS*External HCB

0.99 (0.99–1.00)

GSE, T1

0.89 (0.81–0.98)*

0.88 (0.8–0.97)**

RAPS*GSE

0.98 (0.97–1.00)*

R square

0.35

0.36

0.37

0.35

0.38

0.41